skip to main content
Idioma:
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Discrimination of cytosolic self and non-self RNA by RIG-I-like receptors
Discrimination of cytosolic self and non-self RNA by RIG-I-like receptors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Discrimination of cytosolic self and non-self RNA by RIG-I-like receptors

Lässig, Charlotte ; Hopfner, Karl-Peter

The Journal of biological chemistry, 2017-06, Vol.292 (22), p.9000-9009 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
2
In vivo ligands of MDA5 and RIG-I in measles virus-infected cells
In vivo ligands of MDA5 and RIG-I in measles virus-infected cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

In vivo ligands of MDA5 and RIG-I in measles virus-infected cells

Runge, Simon ; Sparrer, Konstantin M J ; Lässig, Charlotte ; Hembach, Katharina ; Baum, Alina ; García-Sastre, Adolfo ; Söding, Johannes ; Conzelmann, Karl-Klaus ; Hopfner, Karl-Peter Mossman, Karen L.

PLoS pathogens, 2014-04, Vol.10 (4), p.e1004081-e1004081 [Periódico revisado por pares]

United States: Public Library of Science

Texto completo disponível

Citações Citado por
3
ATP hydrolysis by the viral RNA sensor RIG-I prevents unintentional recognition of self-RNA
ATP hydrolysis by the viral RNA sensor RIG-I prevents unintentional recognition of self-RNA
Material Type:
Artigo 		Adicionar ao Meu Espaço

ATP hydrolysis by the viral RNA sensor RIG-I prevents unintentional recognition of self-RNA

Lässig, Charlotte ; Matheisl, Sarah ; Sparrer, Konstantin M J ; de Oliveira Mann, Carina C ; Moldt, Manuela ; Patel, Jenish R ; Goldeck, Marion ; Hartmann, Gunther ; García-Sastre, Adolfo ; Hornung, Veit ; Conzelmann, Karl-Klaus ; Beckmann, Roland ; Hopfner, Karl-Peter

eLife, 2015-11, Vol.4 [Periódico revisado por pares]

England: eLife Science Publications, Ltd

Texto completo disponível

Citações Citado por
4
Unified mechanisms for self-RNA recognition by RIG-I Singleton-Merten syndrome variants
Unified mechanisms for self-RNA recognition by RIG-I Singleton-Merten syndrome variants
Material Type:
Artigo 		Adicionar ao Meu Espaço

Unified mechanisms for self-RNA recognition by RIG-I Singleton-Merten syndrome variants

Lässig, Charlotte ; Lammens, Katja ; Gorenflos López, Jacob Lucián ; Michalski, Sebastian ; Fettscher, Olga ; Hopfner, Karl-Peter

eLife, 2018-07, Vol.7 [Periódico revisado por pares]

England: eLife Sciences Publications, Ltd

Texto completo disponível

Citações Citado por
5
Viral unmasking of cellular 5S rRNA pseudogene transcripts induces RIG-I-mediated immunity
Viral unmasking of cellular 5S rRNA pseudogene transcripts induces RIG-I-mediated immunity
Material Type:
Artigo 		Adicionar ao Meu Espaço

Viral unmasking of cellular 5S rRNA pseudogene transcripts induces RIG-I-mediated immunity

Chiang, Jessica J ; Sparrer, Konstantin M J ; van Gent, Michiel ; Lässig, Charlotte ; Huang, Teng ; Osterrieder, Nikolaus ; Hopfner, Karl-Peter ; Gack, Michaela U

Nature immunology, 2018-01, Vol.19 (1), p.53-62 [Periódico revisado por pares]

United States: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
cGAS senses long and HMGB/TFAM-bound U-turn DNA by forming protein-DNA ladders
cGAS senses long and HMGB/TFAM-bound U-turn DNA by forming protein-DNA ladders
Material Type:
Artigo 		Adicionar ao Meu Espaço

cGAS senses long and HMGB/TFAM-bound U-turn DNA by forming protein-DNA ladders

Andreeva, Liudmila ; Hiller, Björn ; Kostrewa, Dirk ; Lässig, Charlotte ; de Oliveira Mann, Carina C ; Jan Drexler, David ; Maiser, Andreas ; Gaidt, Moritz ; Leonhardt, Heinrich ; Hornung, Veit ; Hopfner, Karl-Peter

Nature (London), 2017-09, Vol.549 (7672), p.394-398 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
Pharmacokinetics (PK) and pharmacodynamics (PD) in First-MIND: A phase Ib, open-label, randomized study of tafasitamab (tafa) ± lenalidomide (LEN) in addition to R-CHOP in patients (pts) with newly diagnosed diffuse large B-cell lymphoma (DLBCL)
Pharmacokinetics (PK) and pharmacodynamics (PD) in First-MIND: A phase Ib, open-label, randomized study of tafasitamab (tafa) ± lenalidomide (LEN) in addition to R-CHOP in patients (pts) with newly diagnosed diffuse large B-cell lymphoma (DLBCL)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pharmacokinetics (PK) and pharmacodynamics (PD) in First-MIND: A phase Ib, open-label, randomized study of tafasitamab (tafa) ± lenalidomide (LEN) in addition to R-CHOP in patients (pts) with newly diagnosed diffuse large B-cell lymphoma (DLBCL)

Belada, David ; Kopeckova, Katerina ; Bergua Burgues, Juan Miguel ; Stevens, Don A. ; Nowakowski, Grzegorz S. ; Waldron-Lynch, Maeve ; Hadar, Nira ; Weirather, Johannes ; Lässig, Charlotte ; Blair, Derek ; Dreyling, Martin H.

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e19553-e19553 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
8
Correction: ATP hydrolysis by the viral RNA sensor RIG-I prevents unintentional recognition of self-RNA
Correction: ATP hydrolysis by the viral RNA sensor RIG-I prevents unintentional recognition of self-RNA
Material Type:
Artigo 		Adicionar ao Meu Espaço

Correction: ATP hydrolysis by the viral RNA sensor RIG-I prevents unintentional recognition of self-RNA

Lässig, Charlotte ; Matheisl, Sarah ; Sparrer, Konstantin Mj ; de Oliveira Mann, Carina C ; Moldt, Manuela ; Patel, Jenish R ; Goldeck, Marion ; Hartmann, Gunther ; García-Sastre, Adolfo ; Hornung, Veit ; Conzelmann, Karl-Klaus ; Beckmann, Roland ; Hopfner, Karl-Peter

eLife, 2016-03, Vol.5 [Periódico revisado por pares]

England: eLife Science Publications, Ltd

Texto completo disponível

Citações Citado por
9
RIG-I-Like Receptors: One STrEP Forward
RIG-I-Like Receptors: One STrEP Forward
Material Type:
Artigo 		Adicionar ao Meu Espaço

RIG-I-Like Receptors: One STrEP Forward

Lässig, Charlotte ; Hopfner, Karl-Peter

Trends in microbiology (Regular ed.), 2016-07, Vol.24 (7), p.517-519 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Poster: ABCL-022 Pharmacokinetics and Pharmacodynamics in First-MIND: A Phase Ib, Open-Label, Randomized Study of Tafasitamab ± Lenalidomide + R-CHOP in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma
Poster: ABCL-022 Pharmacokinetics and Pharmacodynamics in First-MIND: A Phase Ib, Open-Label, Randomized Study of Tafasitamab ± Lenalidomide + R-CHOP in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Poster: ABCL-022 Pharmacokinetics and Pharmacodynamics in First-MIND: A Phase Ib, Open-Label, Randomized Study of Tafasitamab ± Lenalidomide + R-CHOP in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma

Belada, David ; Kopeckova, Katerina ; Burgues, Juan Miguel Bergua ; Stevens, Don ; Nowakowski, Grzegorz S. ; Waldron-Lynch, Maeve ; Hadar, Nira ; Weirather, Johannes ; Lässig, Charlotte ; Blair, Derek ; Dreyling, Martin

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S165 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (17)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (18)
  2. Dissertações  (1)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2013  (1)
  2. 2013Até2013  (3)
  3. 2014Até2014  (3)
  4. 2015Até2016  (4)
  5. Após 2016  (9)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (18)
  2. Japonês  (4)
  3. Alemão  (1)
  4. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.